• Understanding the Critical Role of Lupus Clinical Trial Outcome Measures in Advancing Therapeutic Development

  • Jul 1 2024
  • Duración: 20 m
  • Podcast

Understanding the Critical Role of Lupus Clinical Trial Outcome Measures in Advancing Therapeutic Development  Por  arte de portada

Understanding the Critical Role of Lupus Clinical Trial Outcome Measures in Advancing Therapeutic Development

  • Resumen

  • Join Dr. Anna Wolska from the Lupus Foundation of America and Dr. Laurent Arnaud, Professor of Rheumatology at the Department of Rheumatology, University Hospitals of Strasbourg as they discuss systemic lupus erythematosus (SLE) clinical trials. In this episode, Dr. Arnaud highlights the complexities of drug approval processes in lupus, the pivotal role of large-scale phase three randomized trials and critical outcome measures in these trials, from primary endpoints assessing treatment efficacy to secondary and exploratory measures capturing broader impacts on patient health and quality of life.

    Read the article: https://lupus.bmj.com/content/11/1/e001114

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Understanding the Critical Role of Lupus Clinical Trial Outcome Measures in Advancing Therapeutic Development

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.